Gosling Plague Antibody
- For the treatment and emergency prevention of goslings.
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Gosling Plague Antibody
Composition and Content
Mainly contain gosling scorpion antibody, and the pluripotency is ≥1:16.
Indications
For the treatment and emergency prevention of goslings.
Dosage and Administration
Both subcutaneous and intramuscular injection are applicable.
For emergency prevention: 0.5 mL per gosling for 1-day-old goslings; 0.5–0.8 mL per gosling for goslings aged 2 to 5 days.
For treatment: Administer 1.0–1.5 mL per infected gosling.
Adverse Reactions
Generally, no adverse reactions occur.
Specification
250 ml/bottle, 40 bottles/carton; 500 ml/bottle, 20 bottles/carton.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
Appearance
Slightly brown or light yellow transparent liquid. After 48 hours, there is a slight white precipitate on the bottom of the bottle, and the pH is 6.4-7.2.
1. Dual-Strain Broad Protection
- 1. One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.
- 2. Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.
- 3. Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.
- 4. The vaccine contains composite antigens from classical very virulent Infectious Bursal Disease virus (cvvIBDV) and novel variant IBDV (nvIBDV), offering improved cross-protection against both strains as an upgraded version of the company’s original inactivated IBD vaccine series.
- 5. The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.